- Raised $2M funding round, Feb 2014
- Raised $1M funding round, Feb 2012
- Raised $300k grant, Jul 2011
About
Vascular Graft Solutions (VGS) develops technologies to improve surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas. The company's portfolio includes VEST, an external support for vein grafts in coronary artery bypass surgery, and FRAME, an external support for vein grafts in peripheral revascularization and reconstruction procedures. These devices are designed to target the underlying factors leading to saphenous vein graft disease, including disturbed flow pattern and high wall tension, diameter mismatch between the graft and the hosting artery, and, in particular, progression of intimal hyperplasia. VEST received CE mark approval in 2014 and is commercialized in international markets. FRAME received CE mark approval in late 2017 and is commercialized for several indications, including above- and below-the-knee bypass surgeries and peripheral aneurysm repair. Ongoing IDE-approved studies are being conducted in leading centers in the United States and Canada toward the commercialization of VGS products in the United States. VGS has additional pipeline products in various stages of research and development.
Funding history · 6 rounds · $4.8M total
Q&A
- What is Vascular Graft Solutions' primary focus?
- Vascular Graft Solutions develops technologies to improve surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas.
- What are the key products offered by Vascular Graft Solutions?
- The company's portfolio includes VEST, an external support for vein grafts in coronary artery bypass surgery, and FRAME, an external support for vein grafts in peripheral revascularization and reconstruction procedures.
- When did Vascular Graft Solutions receive CE mark approval for its VEST product?
- VEST received CE mark approval in 2014 and is commercialized in international markets.
- When did Vascular Graft Solutions receive CE mark approval for its FRAME product?
- FRAME received CE mark approval in late 2017 and is commercialized for several indications, including above- and below-the-knee bypass surgeries and peripheral aneurysm repair.
- What is the current employee count for Vascular Graft Solutions?
- Vascular Graft Solutions has 11-50 employees.
- Who founded Vascular Graft Solutions?
- Vascular Graft Solutions was founded by Eyal Orion.
- What is the total amount of funding raised by Vascular Graft Solutions?
- Vascular Graft Solutions has raised a total of $4,800,000.
- When was Vascular Graft Solutions' most recent funding round?
- The company's most recent funding round occurred in February 2019, with Tal Ventures participating.
- Which investor participated in Vascular Graft Solutions' September 2018 funding round?
- Champel Capital participated in Vascular Graft Solutions' funding round in September 2018.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | graftsolutions.com |
|---|---|
| linkedin.com/company/10110013 | |
| facebook.com/vasculargraftsolutions | |
| YouTube | youtube.com/channel/UCwRXq1H7Vi7lp0s1CxvdQVA |
Identifiers & details
| Founded | 2008-12 |
|---|---|
| Employees (exact) | 16 |
Radar intelligence
Patents
| EPO | 11 |
|---|
Web history (Wayback)
| Domain | graftsolutions.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|